Air France-KLM, Adecco, SAP AG, Shell: Europe Equity Preview

By Nadja Brandt

May 19 (Bloomberg) -- The following companies may have unusual price changes in European trading. Stock symbols are in parentheses, and share prices are from the previous close.

The Dow Jones Stoxx 600 increased 2.4 percent to 207.83. The Dow Jones Stoxx 50 Index added 2.6 percent to 2,107.35. The Euro Stoxx 50 Index, a benchmark for the nations using the euro, rose 2.5 percent to 2,422.74.

Adecco SA (ADEN VX): The world’s largest supplier of temporary workers had its outlook lowered to negative from stable by Moody’s Investors Service. The stock added 1.3 francs, or 2.9 percent, to 46.16.

Continental AG (CON GY): Europe’s second-largest car-parts maker and workers at the truck-tire plant at its Hanover, Germany, headquarters are close to a compromise that may prevent the factory’s closure, Deutsche Presse-Agentur reported, citing unidentified people close to the company. The shares climbed 2.5 percent to 19.48 euros.

Air France-KLM Group (AF FP): Europe’s biggest airline reports full-year earnings after the market close in Paris. The company has already forecast an operating loss of about 200 million euros for the period and said it is unlikely to return to profit this year. The shares rose 5.5 cents, or 0.6 percent, to 9.65 euros.

Corio NV (CORA NA): The largest Dutch developer publishes first-quarter results after trading ends in Amsterdam. Corio advanced 47 cents, or 1.4 percent, to 35.30 euros.

Royal Dutch Shell Plc (RDSA NA): Europe’s largest oil company hosts its annual shareholders’ meeting at 11:00 a.m. in The Hague and may give forecasts. Shell added 51 cents, or 2.8 percent, to 18.54 euros.

SAP AG (SAP GY): The world’s largest maker of business- management software plans to hold its annual shareholders meeting. The shares advanced 3.8 percent to 30.70 euros.

Solvay SA (SOLB BB): Belgium’s second-biggest drugmaker by sales obtained access to Huya Bioscience International LLC’s Chinese molecules to speed up development of drugs for cardiovascular diseases. Solvay rose 3.04 euros, or 5 percent, to 64.25 euros.

To contact the reporter on this story: Nadja Brandt in Los Angeles at nbrandt@bloomberg.net